• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与海藻相关的异养型高海拔芽孢杆菌MTCC13046:一种有望用于对抗人类肝细胞腺癌的海洋细菌。

Seaweed-associated heterotrophic Bacillus altitudinis MTCC13046: a promising marine bacterium for use against human hepatocellular adenocarcinoma.

作者信息

Asharaf Sumayya, Chakraborty Kajal

机构信息

Marine Biotechnology Fish Nutrition and Health Division, Central Marine Fisheries Research Institute, Ernakulam North, P.B. No. 1603, Cochin, 682018, Kerala, India.

Faculty of Marine Sciences, Lakeside Campus, Cochin University of Science and Technology, Cochin, Kerala, India.

出版信息

Arch Microbiol. 2022 Dec 2;205(1):10. doi: 10.1007/s00203-022-03346-2.

DOI:10.1007/s00203-022-03346-2
PMID:36459289
Abstract

Since the report of the antibiotic with anticancer properties, scientists have been focusing to isolate and characterize novel anti-microbial natural products possessing anticancer activities. The current study describes the production of seaweed-associated heterotrophic Bacillus altitudinis MTCC13046 with potential anticancer properties. The bacterium was screened for its capacity to diminish the cell proliferation of the human hepatocellular adenocarcinoma (HepG2) cell line, without upsetting the normal cells. The bacterial extract showed anticancer properties in a dose-reactive form against HepG2 (IC, half maximal inhibitory concentration ~ 29.5 µg/ml) on tetrazolium bromide analysis with less significant cytotoxicity on common fibroblast (HDF) cells (IC ~ 77 µg/ml). The potential antioxidant ability of the organic extract of B. altitudinis MTCC13046 (IC 133 µg/ml) could corroborate its capacity to attenuate the pathophysiology leading to carcinogenesis. The results of the apoptosis assay showed that the crude extracts of B. altitudinis maintained 68% viability in normal cells compared to 11% in the cancer cells (IC 76.9 µg/ml). According to the findings, B. altitudinis MTCC13046 could be used to develop prospective anticancer agents.

摘要

自从具有抗癌特性的抗生素被报道以来,科学家们一直致力于分离和鉴定具有抗癌活性的新型抗菌天然产物。当前的研究描述了具有潜在抗癌特性的与海藻相关的异养型高海拔芽孢杆菌MTCC13046的产生。对该细菌进行了筛选,以评估其在不影响正常细胞的情况下减少人肝细胞腺癌(HepG2)细胞系细胞增殖的能力。在溴化四氮唑分析中,该细菌提取物对HepG2呈现剂量反应形式的抗癌特性(IC,半数最大抑制浓度约为29.5微克/毫升),而对普通成纤维细胞(HDF)细胞的细胞毒性较小(IC约为77微克/毫升)。高海拔芽孢杆菌MTCC13046有机提取物的潜在抗氧化能力(IC为133微克/毫升)可以证实其减轻导致癌症发生的病理生理过程的能力。凋亡分析结果表明,高海拔芽孢杆菌的粗提物在正常细胞中的存活率为68%,而在癌细胞中为11%(IC为76.9微克/毫升)。根据这些发现,高海拔芽孢杆菌MTCC13046可用于开发有前景的抗癌药物。

相似文献

1
Seaweed-associated heterotrophic Bacillus altitudinis MTCC13046: a promising marine bacterium for use against human hepatocellular adenocarcinoma.与海藻相关的异养型高海拔芽孢杆菌MTCC13046:一种有望用于对抗人类肝细胞腺癌的海洋细菌。
Arch Microbiol. 2022 Dec 2;205(1):10. doi: 10.1007/s00203-022-03346-2.
2
Seaweed-associated heterotrophic bacteria: new paradigm of prospective anti-infective and anticancer agents.海藻相关的异养细菌:有前景的抗感染和抗癌药物的新范例。
Arch Microbiol. 2021 Apr;203(3):1241-1250. doi: 10.1007/s00203-020-02106-4. Epub 2020 Nov 2.
3
Pharmacological potential of seaweed-associated heterotrophic Firmicutes.海藻相关异养厚壁菌的药理学潜力。
Lett Appl Microbiol. 2022 Oct;75(4):1042-1054. doi: 10.1111/lam.13780. Epub 2022 Jul 13.
4
Pharmacological potential of seaweed-associated heterotrophic bacterium Bacillus atrophaeus.与海藻相关的异养细菌萎缩芽孢杆菌的药理潜力
Arch Microbiol. 2022 Nov 30;205(1):6. doi: 10.1007/s00203-022-03338-2.
5
Marine macroalga-associated heterotroph Bacillus velezensis as prospective therapeutic agent.与海洋大型藻类相关的异养型贝莱斯芽孢杆菌作为潜在的治疗剂。
Arch Microbiol. 2021 May;203(4):1671-1682. doi: 10.1007/s00203-020-02169-3. Epub 2021 Jan 13.
6
Seaweed-associated heterotrophic bacteria: are they future novel sources of antimicrobial agents against drug-resistant pathogens?海藻相关异养菌:它们是对抗耐药病原体的新型抗菌药物的未来潜在来源吗?
Arch Microbiol. 2022 Mar 30;204(4):232. doi: 10.1007/s00203-022-02835-8.
7
Novel amylomacins from seaweed-associated Bacillus amyloliquefaciens as prospective antimicrobial leads attenuating resistant bacteria.海洋来源解淀粉芽孢杆菌中新颖的淀粉菌素作为有前景的抗微生物先导化合物,可减弱耐药菌。
World J Microbiol Biotechnol. 2021 Oct 19;37(12):200. doi: 10.1007/s11274-021-03161-9.
8
Marine macroalga-associated heterotrophic Bacillus velezensis: a novel antimicrobial agent with siderophore mode of action against drug-resistant nosocomial pathogens.海洋大型藻类相关的异养芽孢杆菌韦氏芽孢杆菌:一种新型抗微生物剂,具有针对耐药医院病原体的铁载体作用模式。
Arch Microbiol. 2021 Nov;203(9):5561-5575. doi: 10.1007/s00203-021-02513-1. Epub 2021 Aug 26.
9
Pharmacological properties of marine macroalgae-associated heterotrophic bacteria.海洋大型藻类相关异养细菌的药理学特性
Arch Microbiol. 2019 May;201(4):505-518. doi: 10.1007/s00203-018-1592-1. Epub 2018 Nov 7.
10
Preliminary screening of antioxidant and cytotoxic potential of green seaweed, (Linnaeus) Lamouroux.绿藻(林奈)拉穆鲁抗氧化及细胞毒性潜力的初步筛选
Saudi J Biol Sci. 2022 Apr;29(4):2698-2705. doi: 10.1016/j.sjbs.2021.12.066. Epub 2022 Jan 4.

引用本文的文献

1
Metallo-protease Peptidase M84 from induces ROS-dependent apoptosis in ovarian cancer cells by targeting PAR-1.来自[具体来源未提及]的金属蛋白酶肽酶M84通过靶向蛋白酶激活受体-1(PAR-1)诱导卵巢癌细胞中依赖活性氧(ROS)的细胞凋亡。
iScience. 2024 Apr 26;27(6):109828. doi: 10.1016/j.isci.2024.109828. eCollection 2024 Jun 21.
2
Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae.海洋大型藻类共生芽孢杆菌(Firmicutes)的天然产物和药理特性。
Mar Drugs. 2023 Oct 30;21(11):569. doi: 10.3390/md21110569.